Uruguay Widens Free Meningitis Shots After an Unusual Rise in Cases
Uruguay · Health
Key Facts
—The move. Uruguay’s health ministry widened free meningococcal vaccination to 11- and 12-year-olds from Friday, July 3.
—The trigger. Officials cited an unusual rise in cases this year, with twenty infections and five deaths, three of them children.
—The strain. A single type of the bacteria, known as serogroup C, accounts for about seventy percent of this year’s cases.
—The doses. The government bought 300,000 extra doses of the MenFive vaccine through the regional health body for about 1.3 million dollars.
—The push. Intensified vaccination days run nationwide on July 6, 7 and 8, at public and private clinics alike.
—The message. Officials stressed this is not an outbreak but a preventive step, and coverage will expand toward age 15.
Uruguay has moved to protect more of its young people against a fast-moving and dangerous disease. The expansion of the free Uruguay meningococcal vaccine program follows a worrying rise in cases that has already cost five lives this year.
From Friday, July 3, the Public Health Ministry made the free shot available to children aged eleven and twelve who had not yet received it. The step widens an existing national program rather than replacing it, and officials said coverage would later stretch toward age fifteen.
The disease in question is meningococcal illness, a bacterial infection that can cause meningitis or dangerous blood infections. It can move alarmingly fast and, without prompt treatment, can kill or leave lasting damage within hours.
Why the Uruguay meningococcal vaccine expansion is happening now
The trigger is a jump in cases that health authorities have called unusual for this point in the year. Uruguay has recorded twenty infections in 2026, with five deaths, three of them children, one as young as two months.
Health Minister Cristina Lustemberg was careful with her words, saying the country is not facing an outbreak but a rise that warrants a cautious, preventive response. She noted that three of the five who died had not been vaccinated, while the other two had incomplete protection.
What has shifted is the type of bacteria in circulation. Roughly seventy percent of this year’s cases come from a strain known as serogroup C, a change from the pattern seen in 2025 and the reason officials singled out teenagers, who are among the main carriers.
What is being rolled out
To back the expansion, the government bought three hundred thousand additional doses of a five-strain vaccine sold as MenFive, purchased through the Pan American Health Organization at a cost of about one and a third million dollars. The vaccine guards against five types of the bacteria at once.
To make it easy to get the shot, the ministry set intensified vaccination days across the country on July 6, 7 and 8, run jointly by public and private health providers. Anyone who already completed the vaccine course does not need a booster.
Coverage among eleven-year-olds currently sits near seventy-nine percent, and the goal is to push past ninety percent to strengthen protection across the community. Officials also linked the effort to broader respiratory-illness prevention, since winter infections can raise the risk of meningococcal disease.
What it means for residents and families
For families living in Uruguay, foreign residents included, the practical point is simple. If you have a child in the newly eligible age group who has not had the shot, the coming days are the easiest window to get it, free of charge, at clinics nationwide.
The move also fits Uruguay’s wider reputation for a strong public-health system, one that protects against a long list of diseases at relatively low cost. Some experts argue the age net should be cast even wider, to include younger children, a debate the government says it will keep reviewing.
For now, the message from the authorities is steady rather than alarmed. This is a precaution taken early, they say, and they will keep watching the numbers and adjusting the response as the winter season plays out.
The wider context helps explain why Uruguay reacts fast to a handful of cases. The country runs one of the region’s most respected immunization schedules, protecting against well over a dozen diseases, and it treats early action as cheaper and safer than waiting for numbers to climb.
Meningococcal disease earns that caution because of its speed. A person can go from feeling unwell to critically ill in a matter of hours, which is why officials would rather widen a vaccine net now than manage a larger crisis later.
Who can now get the Uruguay meningococcal vaccine for free?
From July 3, children aged eleven and twelve who had not yet been vaccinated can receive the shot free of charge. This adds to the existing national schedule, and officials say coverage will gradually expand toward age fifteen.
Why did Uruguay expand the program?
The country recorded an unusual rise in cases this year, with twenty infections and five deaths, three of them children. About seventy percent of cases came from the serogroup C strain, prompting a preventive expansion aimed at teenagers, who are key carriers.
Where and when can people get vaccinated?
Intensified vaccination days run nationwide on July 6, 7 and 8 at both public and private clinics. The government bought 300,000 extra doses of the MenFive vaccine through the Pan American Health Organization to support the drive.
More: Uruguay news in English, every day from The Rio Times.
Frequently Asked Questions
Why did Uruguay expand its free meningococcal vaccination program?
Officials cited an unusual rise in meningococcal cases in 2025, with twenty infections and five deaths, three of them children. They described the expansion as a preventive step rather than a response to a declared outbreak.
Which age groups are now covered by Uruguay's free meningococcal vaccine?
From July 3, the free vaccine was extended to 11- and 12-year-olds who had not yet received it, widening an existing national program. Officials stated that coverage would later expand toward age 15.
What vaccine is being used and how many doses did Uruguay purchase?
The government is using the MenFive vaccine, which targets serogroup C, the strain responsible for about 70 percent of this year's cases. Uruguay purchased 300,000 extra doses through a regional health body at a cost of approximately 1.3 million dollars.
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
Read More from The Rio Times